A citation-based method for searching scientific literature

Apoorve Nayyar, Paula D Strassle, Mary R Shen, Jonathan A Black, Kristalyn K Gallagher, Kandace P McGuire. Am J Surg 2018
Times Cited: 4







List of co-cited articles
19 articles co-cited >1



Times Cited
  Times     Co-cited
Similarity


Axillary dissection versus no axillary dissection in patients with sentinel-node micrometastases (IBCSG 23-01): a phase 3 randomised controlled trial.
Viviana Galimberti, Bernard F Cole, Stefano Zurrida, Giuseppe Viale, Alberto Luini, Paolo Veronesi, Paola Baratella, Camelia Chifu, Manuela Sargenti, Mattia Intra,[...]. Lancet Oncol 2013
709
100

Axillary dissection vs no axillary dissection in women with invasive breast cancer and sentinel node metastasis: a randomized clinical trial.
Armando E Giuliano, Kelly K Hunt, Karla V Ballman, Peter D Beitsch, Pat W Whitworth, Peter W Blumencranz, A Marilyn Leitch, Sukamal Saha, Linda M McCall, Monica Morrow. JAMA 2011
75

Sentinel-lymph-node resection compared with conventional axillary-lymph-node dissection in clinically node-negative patients with breast cancer: overall survival findings from the NSABP B-32 randomised phase 3 trial.
David N Krag, Stewart J Anderson, Thomas B Julian, Ann M Brown, Seth P Harlow, Joseph P Costantino, Takamaru Ashikaga, Donald L Weaver, Eleftherios P Mamounas, Lynne M Jalovec,[...]. Lancet Oncol 2010
978
75

What Is the Best Management of cN0pN1(sn) Breast Cancer Patients?
Jana de Boniface, Marcus Schmidt, Jutta Engel, Marjolein L Smidt, Birgitte Vrou Offersen, Toralf Reimer. Breast Care (Basel) 2018
10
50

CAGS and ACS Evidence Based Reviews in Surgery. 40. Axillary dissection versus no axillary dissection in women with invasive breast cancer and sentinel node metastasis.
Steve Latosinsky, Tanya S Berrang, C Suzanne Cutter, Ralph George, Ivo Olivotto, Thomas B Julian, Allen Hayashi, Christopher Baliski, Randall L Croshaw, Kathleen M Erb,[...]. Can J Surg 2012
28
50

Comparative Study between Sentinel Lymph Node Biopsy and Axillary Dissection in Patients with One or Two Lymph Node Metastases.
Jina Lee, Jung Eun Choi, Sei Joong Kim, Sae Byul Lee, Min-Ki Seong, Joon Jeong, Chan Seok Yoon, Bong Kyun Kim, Woo Young Sun. J Breast Cancer 2018
8
50

Safety of avoiding routine use of axillary dissection in early stage breast cancer: a systematic review.
Manon J Pepels, Johanna H M J Vestjens, Maaike de Boer, Marjolein Smidt, Paul J van Diest, George F Borm, Vivianne C G Tjan-Heijnen. Breast Cancer Res Treat 2011
50
50

Significance of sentinel lymph node micrometastases in human breast cancer.
Charles E Cox, John V Kiluk, Adam I Riker, John M Cox, Nathon Allred, Daniel C Ramos, Elisabeth L Dupont, Vesna Vrcel, Nils Diaz, David Boulware. J Am Coll Surg 2008
104
50

Survival and axillary recurrence following sentinel node-positive breast cancer without completion axillary lymph node dissection: the randomized controlled SENOMAC trial.
Jana de Boniface, Jan Frisell, Yvette Andersson, Leif Bergkvist, Johan Ahlgren, Lisa Rydén, Roger Olofsson Bagge, Malin Sund, Hemming Johansson, Dan Lundstedt. BMC Cancer 2017
65
50

Is completion axillary lymph node dissection necessary in patients who are underrepresented in the ACOSOG Z0011 trial?
Brian J Gebhardt, Joel Thomas, Zachary D Horne, Colin E Champ, Daniel J Farrugia, Emilia Diego, Gretchen M Ahrendt, Sushil Beriwal. Adv Radiat Oncol 2018
10
50

Low locoregional failure rates in selected breast cancer patients with tumor-positive sentinel lymph nodes who do not undergo completion axillary dissection.
Rosa F Hwang, Ana M Gonzalez-Angulo, Min Yi, Thomas A Buchholz, Funda Meric-Bernstam, Henry M Kuerer, Gildy V Babiera, Welela Tereffe, Diane D Liu, Kelly K Hunt. Cancer 2007
113
50

Locoregional recurrence after sentinel lymph node dissection with or without axillary dissection in patients with sentinel lymph node metastases: the American College of Surgeons Oncology Group Z0011 randomized trial.
Armando E Giuliano, Linda McCall, Peter Beitsch, Pat W Whitworth, Peter Blumencranz, A Marilyn Leitch, Sukamal Saha, Kelly K Hunt, Monica Morrow, Karla Ballman. Ann Surg 2010
793
50

Locoregional Recurrence After Sentinel Lymph Node Dissection With or Without Axillary Dissection in Patients With Sentinel Lymph Node Metastases: Long-term Follow-up From the American College of Surgeons Oncology Group (Alliance) ACOSOG Z0011 Randomized Trial.
Armando E Giuliano, Karla Ballman, Linda McCall, Peter Beitsch, Pat W Whitworth, Peter Blumencranz, A Marilyn Leitch, Sukamal Saha, Monica Morrow, Kelly K Hunt. Ann Surg 2016
256
50


A nomogram for predicting the likelihood of additional nodal metastases in breast cancer patients with a positive sentinel node biopsy.
Kimberly J Van Zee, Donna-Marie E Manasseh, Jose L B Bevilacqua, Susan K Boolbol, Jane V Fey, Lee K Tan, Patrick I Borgen, Hiram S Cody, Michael W Kattan. Ann Surg Oncol 2003
570
50

An axilla scoring system to predict non-sentinel lymph node status in breast cancer patients with sentinel lymph node involvement.
Emmanuel Barranger, Charles Coutant, Antoine Flahault, Yann Delpech, Emile Darai, Serge Uzan. Breast Cancer Res Treat 2005
191
50

New models and online calculator for predicting non-sentinel lymph node status in sentinel lymph node positive breast cancer patients.
Holbrook E Kohrt, Richard A Olshen, Honnie R Bermas, William H Goodson, Douglas J Wood, Solomon Henry, Robert V Rouse, Lisa Bailey, Vicki J Philben, Frederick M Dirbas,[...]. BMC Cancer 2008
181
50

Effect of Axillary Dissection vs No Axillary Dissection on 10-Year Overall Survival Among Women With Invasive Breast Cancer and Sentinel Node Metastasis: The ACOSOG Z0011 (Alliance) Randomized Clinical Trial.
Armando E Giuliano, Karla V Ballman, Linda McCall, Peter D Beitsch, Meghan B Brennan, Pond R Kelemen, David W Ollila, Nora M Hansen, Pat W Whitworth, Peter W Blumencranz,[...]. JAMA 2017
588
50

Radiotherapy or surgery of the axilla after a positive sentinel node in breast cancer (EORTC 10981-22023 AMAROS): a randomised, multicentre, open-label, phase 3 non-inferiority trial.
Mila Donker, Geertjan van Tienhoven, Marieke E Straver, Philip Meijnen, Cornelis J H van de Velde, Robert E Mansel, Luigi Cataliotti, A Helen Westenberg, Jean H G Klinkenbijl, Lorenzo Orzalesi,[...]. Lancet Oncol 2014
845
50

Widespread Implications of ACOSOG Z0011: Effect on Total Mastectomy Patients.
Timothy C Kenny, James Dove, Mohsen Shabahang, Nicole Woll, Marie Hunsinger, April Morgan, Joseph Blansfield. Am Surg 2016
8
25

Axillary recurrence rate 5 years after negative sentinel node biopsy for breast cancer.
Y Andersson, J de Boniface, P-E Jönsson, C Ingvar, G Liljegren, L Bergkvist, J Frisell. Br J Surg 2012
26
25

Axillary dissection versus no axillary dissection in patients with breast cancer and sentinel-node micrometastases (IBCSG 23-01): 10-year follow-up of a randomised, controlled phase 3 trial.
Viviana Galimberti, Bernard F Cole, Giuseppe Viale, Paolo Veronesi, Elisa Vicini, Mattia Intra, Giovanni Mazzarol, Samuele Massarut, Janez Zgajnar, Mario Taffurelli,[...]. Lancet Oncol 2018
188
25

Validation of data quality in the Swedish National Register for Breast Cancer.
Lars Löfgren, Sandra Eloranta, Kamilla Krawiec, Annette Asterkvist, Charlotta Lönnqvist, Kerstin Sandelin. BMC Public Health 2019
27
25

Pragmatic Trials.
Ian Ford, John Norrie. N Engl J Med 2016
628
25

Axillary recurrence after a tumour-negative sentinel node biopsy in breast cancer patients: A systematic review and meta-analysis of the literature.
I M C van der Ploeg, O E Nieweg, M C van Rijk, R A Valdés Olmos, B B R Kroon. Eur J Surg Oncol 2008
128
25

Assessment of pathologic prognostic factors in breast core needle biopsies.
S Sharifi, M K Peterson, J K Baum, S Raza, S J Schnitt. Mod Pathol 1999
51
25

Axillary metastasis in clinically node-negative breast cancer.
Orhan Üreyen, Demet Kocatepe Çavdar, Zehra Hilal Adıbelli, Enver İlhan. J Egypt Natl Canc Inst 2018
3
33

Factors predicting the sentinel node metastases in T1 breast cancer tumor: an analysis of 1416 cases.
J Capdet, P Martel, H Charitansky, Y K T Lim, G Ferron, L Battle, A Landier, E Mery, S Zerdoub, H Roche,[...]. Eur J Surg Oncol 2009
24
25

Correlation of histologic prognostic factors in core biopsies and therapeutic excisions of invasive breast carcinoma.
Gavin C Harris, Helen E Denley, Sarah E Pinder, Andrew H S Lee, Ian O Ellis, Christopher W Elston, Andrew Evans. Am J Surg Pathol 2003
93
25

Prevalence and significance of perineural invasion in invasive breast carcinoma.
Soma Ghosh Karak, Nicola Quatrano, Judith Buckley, Andrew Ricci. Conn Med 2010
20
25

Recommendations for human epidermal growth factor receptor 2 testing in breast cancer: American Society of Clinical Oncology/College of American Pathologists clinical practice guideline update.
Antonio C Wolff, M Elizabeth H Hammond, David G Hicks, Mitch Dowsett, Lisa M McShane, Kimberly H Allison, Donald C Allred, John M S Bartlett, Michael Bilous, Patrick Fitzgibbons,[...]. J Clin Oncol 2013
25

Prognostic implication of the primary tumor location in early-stage breast cancer: focus on lower inner zone.
Jiqiao Yang, Shenli Tang, Yuting Zhou, Juanjuan Qiu, Juying Zhang, Sui Zhu, Qing Lv. Breast Cancer 2018
15
25

Lymphangiogenesis in breast cancer is associated with non-sentinel lymph node metastases in sentinel node positive patients.
Lin Lv, Rui-Min Ma, Fan Yang, Xiao-Hua Zhang, Du-Ping Huang. Int J Clin Exp Pathol 2015
1
100

Predictive factors for additional non-sentinel lymph node involvement in breast cancer patients with one positive sentinel node.
Icro Meattini, Calogero Saieva, Silvia Bertocci, Giulio Francolini, Giacomo Zei, Carla De Luca Cardillo, Vieri Scotti, Daniela Greto, Pierluigi Bonomo, Lorenzo Orzalesi,[...]. Tumori 2015
6
25


Predictive factors associated with axillary lymph node metastases in T1a and T1b breast carcinomas: analysis in more than 900 patients.
D E Rivadeneira, R M Simmons, P J Christos, K Hanna, J M Daly, M P Osborne. J Am Coll Surg 2000
116
25

Prognostic and predictive factors in breast cancer by immunohistochemical analysis.
D C Allred, J M Harvey, M Berardo, G M Clark. Mod Pathol 1998
25

Nonsentinel node metastasis in breast cancer patients: assessment of an existing and a new predictive nomogram.
Amy C Degnim, Carol Reynolds, Gouri Pantvaidya, Shaheen Zakaria, Tanya Hoskin, Sunni Barnes, Margaret V Roberts, Peter C Lucas, Kevin Oh, Meryem Koker,[...]. Am J Surg 2005
183
25

Clinicopathologic factors predicting involvement of nonsentinel axillary nodes in women with breast cancer.
Rosa F Hwang, Savitri Krishnamurthy, Kelly K Hunt, Nadeem Mirza, Frederick C Ames, Barry Feig, Henry M Kuerer, S Eva Singletary, Gildy Babiera, Funda Meric,[...]. Ann Surg Oncol 2003
215
25

High risk of non-sentinel node metastases in a group of breast cancer patients with micrometastases in the sentinel node.
Tove Filtenborg Tvedskov, Maj-Britt Jensen, Ida Marie Lisse, Bent Ejlertsen, Eva Balslev, Niels Kroman. Int J Cancer 2012
20
25

Predictors of non-sentinel lymph node metastasis in breast cancer patients.
A Goyal, A Douglas-Jones, R G Newcombe, R E Mansel. Eur J Cancer 2004
71
25

The incidence and risk factors of related lymphedema for breast cancer survivors post-operation: a 2-year follow-up prospective cohort study.
Li Zou, Feng-Hua Liu, Pei-Pei Shen, Yan Hu, Xiao-Qian Liu, Ying-Ying Xu, Qi-Liang Pen, Bei Wang, Ya-Qun Zhu, Ye Tian. Breast Cancer 2018
49
25

Clinicopathological parameters and biological markers predicting non-sentinel node metastasis in sentinel node-positive breast cancer patients.
Youngmee Kwon, Jungsil Ro, Han-Sung Kang, Seok Ki Kim, Eun Kyung Hong, Shin Kwang Khang, Gyungyub Gong, Jae Y Ro. Oncol Rep 2011
25
25

Prediction of additional lymph node involvement in breast cancer patients with positive sentinel lymph nodes.
K Pohlodek, S Bozikova, I Meciarova, V Mucha, M Bartova, F Ondrias. Neoplasma 2016
7
25

Utility of pre-treatment neutrophil-lymphocyte ratio and platelet-lymphocyte ratio as prognostic factors in breast cancer.
C-H Koh, N Bhoo-Pathy, K-L Ng, R S Jabir, G-H Tan, M-H See, S Jamaris, N A Taib. Br J Cancer 2015
195
25

Prediction of non-sentinel lymph node involvement in breast cancer patients with a positive sentinel lymph node.
Anneleen Reynders, Olivier Brouckaert, Ann Smeets, Annouschka Laenen, Emi Yoshihara, Frederik Persyn, Giuseppe Floris, Karin Leunen, Frederic Amant, Julie Soens,[...]. Breast 2014
12
25

Can Neutrophil to Lymphocyte Ratio Be a Predictor Tool for The Non-Sentinel Lymph Node Metastasis in Breast Cancer?
Atak Ibrahim, Yegen Fatih Serkan, Atak Tuba, Bagcivan Erol, Polat Lütfi. Chirurgia (Bucur) 2019
2
50

Sentinel Lymph Node Biopsy for Patients With Early-Stage Breast Cancer: American Society of Clinical Oncology Clinical Practice Guideline Update.
Gary H Lyman, Mark R Somerfield, Linda D Bosserman, Cheryl L Perkins, Donald L Weaver, Armando E Giuliano. J Clin Oncol 2017
214
25

Prediction of nonsentinel lymph node metastasis in breast cancer patients with one or two positive sentinel lymph nodes.
Bahadır Öz, Alper Akcan, Serap Doğan, Ümmühan Abdulrezzak, Dicle Aslan, Erdoğan Sözüer, Ertan Emek, Muhammet Akyüz, Ferhan Elmalı, Engin Ok. Asian J Surg 2018
10
25



Co-cited is the co-citation frequency, indicating how many articles cite the article together with the query article. Similarity is the co-citation as percentage of the times cited of the query article or the article in the search results, whichever is the lowest. These numbers are calculated for the last 100 citations when articles are cited more than 100 times.